To the Point Eyetube
-
- Science
-
To the Point is a podcast aimed at helping optometrists build their dry eye practices.
-
New Practice, Noh Problem: Lessons From Opening a Cold Start Practice
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, welcome this month’s guest, Ada Noh, OD. Dr. Noh shares her story of how she came to open her very own practice, dedicated solely to dry eye, in a brand new city. She talks about building up her patient base, networking with local providers, and lessons she learned along the way.
-
Is Radio Frequency a Worthwhile Investment for Your Dry Eye Toolkit?
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, interview Keylee Brown, OD, to learn how she came to offer radio frequency therapy in her dry eye clinic. Dr. Brown talks about how the technology works with intense pulsed light, how she educates patients about it, fits it into her workflow, and the rewarding clinical results she has witnessed since purchasing the device.
-
Treating OSD in 2024
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, kick off 2024 with a conversation about several new and anticipated products for treating ocular surface disease, including cyclosporine ophthalmic solution 0.1% (Vevye, Harrow), perfluorohexyloctane ophthalmic solution (Meibo, Bausch + Lomb), and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals). They also share some practice pearls and professional goals for the year ahead.
-
Dry Eye From a Neuro Perspective
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, welcome guest Jacqueline Theis, OD, FAAO, who shares her pearls for treating patients with dry eye and a neurologic condition or injury. She explains how to determine whether a patient’s dry eye symptoms are simply dry eye alone, or if they may be related to neurologic problem, and what to do if they are.
-
Considerations for Use of Two Newly Approved Drugs
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.
-
A New Perspective for To the Point
This month on To the Point, Jackie Garlich, OD, FAAO, introduces her new co-host, Jessilin Quint, OD, MS, MBA, FAAO. Dr. Quint shares her background and journey in optometry, including how she came to open her dry eye and aesthetics clinic 2 years ago in Maine.
Customer Reviews
Dry Eye Needs Attention!
I’m so glad this podcast is shining light on the seriousness of dry eye. It’s so widespread and so important to treat aggressively. I’m shocked at how many eye doctors dismiss it. It contributes to far worse conditions and people need awareness of that.
I’ve been helping my brother find help for his severe photophobia, recurrent bouts of iritis, and suspected corneal neuralgia for several months. It’s been an education! Good doctors who I’m sure would like to have helped his crippling photophobia never told us that dry eye is the leading cause. They remarked that he had signs of dry eye, but didn’t ever make the connection or treat it seriously. Once we found a dry eye specialist who began aggressive treatment, he finally started having small improvements.
Why do so many doctors fail to treat DED seriously when I, as a layperson, can discover through online research available to all that it underlies many difficult and painful eye conditions? People are suffering needlessly.
💯💯💯
Thanks for your very interesting and clinically relevant updates and discussions...GREAT job!